Blood -- Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)

Blood, Vol. 114, Issue 12, 2393-2400, September 17, 2009

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)
Blood Greenberg et al. 114: 2393

Supplemental materials for: Greenberg et al

Files in this Data Supplement:

Document 1. ECOG 1996 investigators (PDF, 61.3 KB)